Loading clinical trials...
Loading clinical trials...
Interstitial lung disease (ILD) is the result of over 200 etiological pathways arising from several different insults to the lung parenchyma: inhaled substances, drug side effects, connective tissue d...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Institutes of Health Clinical Center (CC)
Collaborators
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT06329401 · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, and more
NCT07451977 · Chronic Respiratory Failure, Hypoxemia, and more
NCT07484243 · Rheumatoid Arthritis (RA), Rheumatoid Arthritis-Associated Interstitial Lung Disease, and more
NCT06817590 · Telomere Biology Disorders, Dyskeratosis Congenita, and more
National Institutes of Health Clinical Center
Bethesda, Maryland
INOVA Fairfax Hospital
Falls Church, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions